(Q51486996)

5 April 2018

title

Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. (English)

1 reference

5 April 2018

0 references

0 references

1 reference

Watanabe S

1

1 reference

5 April 2018

Pereira J

series ordinal

2

1 reference

5 April 2018

Hanson J

series ordinal

3

1 reference

5 April 2018

Bruera E

series ordinal

4

1 reference

5 April 2018

publication date

1 November 1998

1 reference

5 April 2018

Journal of Pain and Symptom Management

published in

1 reference

5 April 2018

volume

16

1 reference

5 April 2018

issue

5

1 reference

5 April 2018

page(s)

323-326

1 reference

5 April 2018

The treatment of cancer pain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Clinical pharmacokinetics of fentanyl and its newer derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Guidelines for the clinical use of transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

1 reference

7 January 2021

Day-to-day titration of transdermal fentanyl is unwise

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900095-5

7 January 2021

10.1016/S0885-3924(98)00095-5

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018